Disease-free and overall survival (per-protocol analysis) according to disease type at relapse and disease status at transplantation. (A) DFS of patients according to disease type (NHL, continuous line, versus HD, dashed line; P = .01). (B) DFS of patients according to disease status at transplantation (chemosensitive, continuous line, vs chemoresistant, dashed line; P = .007).